The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice
about
Role of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseTau phosphorylation and μ-calpain activation mediate the dexamethasone-induced inhibition on the insulin-stimulated Akt phosphorylation.Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance.Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's diseaseFinding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissueHippocampal calcium dysregulation at the nexus of diabetes and brain aging.Expression of human apolipoprotein E4 reduces insulin-receptor substrate 1 expression and Akt phosphorylation in the ageing liver.Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and MetabolomeTherapeutic Actions of the Thiazolidinediones in Alzheimer's Disease.Toll-interacting protein deficiency promotes neurodegeneration via impeding autophagy completion in high-fat diet-fed ApoE-/- mouse model.Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before: ApoE, APP transcription and AD: Hypothesised mechanisms and existing knowledge gaps.Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease.Neuroinflammation is not a Prerequisite for Diabetes-induced Tau Phosphorylation.Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study.
P2860
Q28083039-6656F7F5-1AFD-407C-AF56-B7593651174BQ34247526-B75CAD6C-999F-4653-9E53-F9EA9C59F4D2Q34477327-396C7B28-81D2-4244-882E-E5758D2B14F2Q36044265-00578960-FB1F-406E-BC9F-0DC22FDB5BD6Q36925690-2994ED0F-B055-43DC-9042-7056ED9E2565Q37337291-4DEC514F-D6A1-4462-AFED-2AF1BAC4BF96Q37645475-C6C8A961-6375-4A42-851E-6C55F553328CQ37685927-1CC11768-6997-46AE-8250-3D54DF5CF4D5Q38639674-9D0E0D53-439D-45A3-99C5-B96B57AC0B70Q39308308-AE85AAAA-12DC-4B2E-944C-DA8DF561E0ADQ39450295-B5B95FE0-CD06-45AC-AA7E-A2230B5AB377Q42656054-3DF03CEA-966A-46A8-B94A-68558897807EQ43184034-14AD8024-8647-42BA-BD80-E49F49657B29Q43896071-497B35A0-4A03-4747-A39A-371FCD951469Q50035045-932CD41B-AC59-4B1C-9647-A59AF77F767BQ55154216-F4754549-3FFA-4735-BB3D-3F356861063B
P2860
The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@ast
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@en
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@nl
type
label
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@ast
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@en
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@nl
prefLabel
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@ast
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@en
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@nl
P2093
P2860
P3181
P1433
P1476
The ε3 and ε4 alleles of human ...... and pioglitazone treated mice
@en
P2093
Alvina W M To
Joern E Schroeder
Tsu Tshen Chuang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0016991
P407
P577
2011-02-10T00:00:00Z